BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2538905)

  • 1. [Comparison of the osteoprotective effects of orally administered equine conjugated estrogens and percutaneous 17 beta-estradiol].
    Reginster JY; Sarlet N; Deroisy R; Denis D; Lecart MP; Franchimont P
    Rev Med Liege; 1989 Jan; 44(2):55-60. PubMed ID: 2538905
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of osteoporosis by the gynecologist].
    Schneider HP; Dören M
    Zentralbl Gynakol; 1994; 116(12):691-4. PubMed ID: 7846982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transdermal estrogenic therapy in menopause].
    Nencioni T; Polvani F; Penotti M; Porcaro E; Barbieri Carones M
    Minerva Endocrinol; 1989; 14(1):49-52. PubMed ID: 2543896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different effects of oral conjugated equine estrogens and transdermal estrogen on undercarboxylated osteocalcin concentration in postmenopausal women.
    Yasui T; Uemura H; Tomita J; Umino Y; Yamada M; Kuwahara A; Matsuzaki T; Maegawa M; Miura M; Irahara M
    Menopause; 2006; 13(4):651-9. PubMed ID: 16837887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fate of a large bolus of exogenous estrogen administered to postmenopausal women.
    Greenblatt RB; Natrajan PK; Aksu MF; Tzingounis VA
    Maturitas; 1980 Jan; 2(1):29-35. PubMed ID: 6250009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mental tonic effect of oestrogens administered to oöphorectomized females.
    Utian WH
    S Afr Med J; 1972 Aug; 46(31):1079-82. PubMed ID: 4341416
    [No Abstract]   [Full Text] [Related]  

  • 7. Menorest: a clinical overview.
    Wren B
    Int J Gynaecol Obstet; 1996 Mar; 52 Suppl 1():S27-9. PubMed ID: 8666124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Action of drugs in relation to the administration route].
    Di Carlo F
    Minerva Endocrinol; 1989; 14(1):41-4. PubMed ID: 2543894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-menopausal osteoporosis and estrogens. Who should be treated and why.
    Saville PD
    Postgrad Med; 1984 Feb; 75(2):135-8, 142-3. PubMed ID: 6320148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogens in the menopause and postmenopause.
    Rogers J
    N Engl J Med; 1969 Feb; 280(7):364-7. PubMed ID: 4302987
    [No Abstract]   [Full Text] [Related]  

  • 11. Quality of life assessment in a chemoprevention trial: fenretinide and oral or transdermal HRT.
    Serrano D; Mariani L; Mora S; Guerrieri-Gonzaga A; Cazzaniga M; Daldoss C; Ramazzotto F; Feroce I; Decensi A; Bonanni B
    Maturitas; 2006 Aug; 55(1):69-75. PubMed ID: 16500052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative controlled trial of a novel oral estrogen therapy, estradiol acetate, for relief of menopause symptoms.
    Utian WH; Speroff L; Ellman H; Dart C
    Menopause; 2005; 12(6):708-15. PubMed ID: 16278614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estradiol associated with lower thrombotic risk than conjugated equine estrogens when used as oral HRT.
    Brown S
    Menopause Int; 2013 Dec; 19(4):145. PubMed ID: 24479171
    [No Abstract]   [Full Text] [Related]  

  • 14. Biologic effects of transdermal estradiol.
    Chetkowski RJ; Meldrum DR; Steingold KA; Randle D; Lu JK; Eggena P; Hershman JM; Alkjaersig NK; Fletcher AP; Judd HL
    N Engl J Med; 1986 Jun; 314(25):1615-20. PubMed ID: 3012339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women.
    Sumino H; Ichikawa S; Kasama S; Takahashi T; Kumakura H; Takayama Y; Kanda T; Kurabayashi M
    Atherosclerosis; 2006 Dec; 189(2):436-42. PubMed ID: 16469323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical effectiveness of a new matrix plaster: an overview].
    Schindler AE; Schindler EM
    Zentralbl Gynakol; 1995; 117(10):508-9. PubMed ID: 7491832
    [No Abstract]   [Full Text] [Related]  

  • 17. [Are estrogens contraindicated in breast carcinoma?].
    Gabius S; Blossey HC; Teichmann A; Nagel GA
    Dtsch Med Wochenschr; 1988 Nov; 113(45):1774-8. PubMed ID: 2846255
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of the short-term effects of oral conjugated equine estrogens versus transdermal estradiol on C-reactive protein, other serum markers of inflammation, and other hepatic proteins in naturally menopausal women.
    Shifren JL; Rifai N; Desindes S; McIlwain M; Doros G; Mazer NA
    J Clin Endocrinol Metab; 2008 May; 93(5):1702-10. PubMed ID: 18303079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Types of estrogen and delivery systems.
    Whitehead MI
    Postgrad Med; 1989 Apr; Spec No():78-83; discussion 89-90. PubMed ID: 2542912
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical experience with transdermal estradiol in the treatment of the climacteric.
    Utian WH
    Minerva Endocrinol; 1989; 14(1):45-8. PubMed ID: 2543895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.